Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO22608 | Excoecaria agallocha | Species | Euphorbiaceae | Eukaryota | stems and twigs | Beihai, Guangxi province, China | 2008-JAN |
PMID[22196120] |
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | HerDing* | |||
NPO26880 | Mallotus japonicus | Species | Euphorbiaceae | Eukaryota |
PMID[11520216] |
|||
NPO29801 | Mallotus philippinensis | Species | Salangidae | Eukaryota |
PMID[11520216] |
|||
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | TM-MC* | |||
NPO28450 | Phyllanthus emblica | Species | Phyllanthaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | IC50 | = | 70000 | nM | 10.1016/S0960-894X(00)80422-9 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | = | 50000 | nM | 10.1016/S0960-894X(00)80422-9 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Therapeutic index | = | 1.4 | 10.1016/S0960-894X(00)80422-9 | |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | Inhibition | = | 33 | % | 10.1016/S0960-894X(00)80422-9 |
NPT459 | Individual Protein | Human immunodeficiency virus type 1 reverse transcriptase | Human immunodeficiency virus 1 | Inhibition | = | 38 | % | 10.1016/S0960-894X(00)80422-9 |
NPT326 | Individual Protein | Squalene monooxygenase | Rattus norvegicus | IC50 | = | 10000 | nM | 11520216 |
NPT672 | Cell Line | TE-671 | Homo sapiens | ED50 | > | 10 | ug/ml | 1431932 |
NPT180 | Cell Line | HCT-8 | Homo sapiens | ED50 | > | 10 | ug/ml | 1431932 |
NPT81 | Cell Line | A549 | Homo sapiens | ED50 | > | 10 | ug/ml | 1431932 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | > | 10 | ug/ml | 1431932 |
NPT2 | Others | Unspecified | ED50 | = | 0.67 | ug/ml | 1431932 | |
NPT2 | Others | Unspecified | IC50 | > | 10 | ug/ml | 22196120 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 33573.76 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 57147.86 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 41591.06 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 28183.83 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 41975.9 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 42461.96 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 38106.58 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 33189.45 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 79067.86 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 32136.61 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 45394.16 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 26730.06 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 62230.03 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 72610.6 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 47973.34 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 79067.86 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 78886.01 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 36391.5 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 76383.58 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 74816.95 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 86496.79 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 64120.96 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 75683.29 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 39536.66 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 71614.34 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 17947.34 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 49090.79 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 99311.6 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC170203 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9422 | High Similarity | NPC475360 |
0.9353 | High Similarity | NPC473713 |
0.9314 | High Similarity | NPC201814 |
0.9231 | High Similarity | NPC72249 |
0.9172 | High Similarity | NPC138927 |
0.9128 | High Similarity | NPC297574 |
0.9128 | High Similarity | NPC233994 |
0.9128 | High Similarity | NPC268533 |
0.9128 | High Similarity | NPC154741 |
0.9128 | High Similarity | NPC296018 |
0.9128 | High Similarity | NPC211532 |
0.9123 | High Similarity | NPC4390 |
0.9118 | High Similarity | NPC235260 |
0.9118 | High Similarity | NPC149011 |
0.9118 | High Similarity | NPC155763 |
0.9118 | High Similarity | NPC212748 |
0.9118 | High Similarity | NPC204937 |
0.9118 | High Similarity | NPC20505 |
0.9112 | High Similarity | NPC48640 |
0.9112 | High Similarity | NPC149244 |
0.9112 | High Similarity | NPC116745 |
0.9112 | High Similarity | NPC45400 |
0.9107 | High Similarity | NPC475738 |
0.9107 | High Similarity | NPC165720 |
0.9086 | High Similarity | NPC231254 |
0.9075 | High Similarity | NPC37668 |
0.9075 | High Similarity | NPC267680 |
0.9075 | High Similarity | NPC113836 |
0.9075 | High Similarity | NPC253521 |
0.9075 | High Similarity | NPC293626 |
0.9075 | High Similarity | NPC217387 |
0.9075 | High Similarity | NPC476773 |
0.9075 | High Similarity | NPC196127 |
0.9075 | High Similarity | NPC258044 |
0.907 | High Similarity | NPC115760 |
0.907 | High Similarity | NPC171706 |
0.907 | High Similarity | NPC253685 |
0.907 | High Similarity | NPC237435 |
0.907 | High Similarity | NPC43211 |
0.907 | High Similarity | NPC477848 |
0.907 | High Similarity | NPC210094 |
0.907 | High Similarity | NPC101191 |
0.907 | High Similarity | NPC135277 |
0.907 | High Similarity | NPC49344 |
0.9064 | High Similarity | NPC175107 |
0.9064 | High Similarity | NPC153755 |
0.9064 | High Similarity | NPC235575 |
0.9064 | High Similarity | NPC190003 |
0.9059 | High Similarity | NPC229687 |
0.9056 | High Similarity | NPC3474 |
0.9053 | High Similarity | NPC21100 |
0.9053 | High Similarity | NPC197285 |
0.9053 | High Similarity | NPC254306 |
0.9048 | High Similarity | NPC88043 |
0.904 | High Similarity | NPC119094 |
0.904 | High Similarity | NPC41845 |
0.904 | High Similarity | NPC142291 |
0.904 | High Similarity | NPC173872 |
0.904 | High Similarity | NPC7839 |
0.9034 | High Similarity | NPC261623 |
0.9034 | High Similarity | NPC111490 |
0.9023 | High Similarity | NPC212290 |
0.9023 | High Similarity | NPC244903 |
0.9023 | High Similarity | NPC80956 |
0.9017 | High Similarity | NPC144097 |
0.9017 | High Similarity | NPC61904 |
0.9017 | High Similarity | NPC472384 |
0.9017 | High Similarity | NPC472380 |
0.9017 | High Similarity | NPC257714 |
0.9017 | High Similarity | NPC472382 |
0.9017 | High Similarity | NPC472385 |
0.9017 | High Similarity | NPC198324 |
0.9012 | High Similarity | NPC175230 |
0.9012 | High Similarity | NPC263119 |
0.9012 | High Similarity | NPC34436 |
0.9012 | High Similarity | NPC166674 |
0.9012 | High Similarity | NPC172033 |
0.9012 | High Similarity | NPC473550 |
0.9012 | High Similarity | NPC46640 |
0.9012 | High Similarity | NPC88560 |
0.9012 | High Similarity | NPC219600 |
0.9006 | High Similarity | NPC181778 |
0.9006 | High Similarity | NPC471416 |
0.9006 | High Similarity | NPC244776 |
0.9006 | High Similarity | NPC245014 |
0.9006 | High Similarity | NPC282987 |
0.9006 | High Similarity | NPC206123 |
0.9006 | High Similarity | NPC34287 |
0.9006 | High Similarity | NPC84265 |
0.9006 | High Similarity | NPC285197 |
0.9006 | High Similarity | NPC116864 |
0.9006 | High Similarity | NPC224462 |
0.9 | High Similarity | NPC226304 |
0.9 | High Similarity | NPC325555 |
0.9 | High Similarity | NPC42892 |
0.9 | High Similarity | NPC298847 |
0.9 | High Similarity | NPC160156 |
0.9 | High Similarity | NPC229729 |
0.9 | High Similarity | NPC275454 |
0.9 | High Similarity | NPC92565 |
0.9 | High Similarity | NPC265530 |
0.8994 | High Similarity | NPC55786 |
0.8994 | High Similarity | NPC34531 |
0.8994 | High Similarity | NPC240431 |
0.8994 | High Similarity | NPC19388 |
0.8994 | High Similarity | NPC277205 |
0.8988 | High Similarity | NPC22324 |
0.8983 | High Similarity | NPC65489 |
0.8971 | High Similarity | NPC469371 |
0.8971 | High Similarity | NPC473073 |
0.8971 | High Similarity | NPC53680 |
0.8971 | High Similarity | NPC473071 |
0.8971 | High Similarity | NPC208797 |
0.8966 | High Similarity | NPC476619 |
0.8966 | High Similarity | NPC476621 |
0.8966 | High Similarity | NPC476623 |
0.8966 | High Similarity | NPC476622 |
0.8966 | High Similarity | NPC217520 |
0.8966 | High Similarity | NPC476620 |
0.8966 | High Similarity | NPC476618 |
0.8966 | High Similarity | NPC173837 |
0.8966 | High Similarity | NPC139571 |
0.8966 | High Similarity | NPC35167 |
0.896 | High Similarity | NPC223426 |
0.896 | High Similarity | NPC34267 |
0.896 | High Similarity | NPC214621 |
0.896 | High Similarity | NPC472607 |
0.896 | High Similarity | NPC264735 |
0.896 | High Similarity | NPC108202 |
0.896 | High Similarity | NPC81042 |
0.8953 | High Similarity | NPC472386 |
0.8953 | High Similarity | NPC211594 |
0.8953 | High Similarity | NPC117260 |
0.8953 | High Similarity | NPC245452 |
0.8953 | High Similarity | NPC26230 |
0.8953 | High Similarity | NPC172807 |
0.8953 | High Similarity | NPC205076 |
0.8953 | High Similarity | NPC261254 |
0.8953 | High Similarity | NPC48773 |
0.8953 | High Similarity | NPC476405 |
0.8953 | High Similarity | NPC60735 |
0.8953 | High Similarity | NPC67134 |
0.8953 | High Similarity | NPC307518 |
0.8953 | High Similarity | NPC47140 |
0.8953 | High Similarity | NPC38438 |
0.8953 | High Similarity | NPC254540 |
0.8947 | High Similarity | NPC476771 |
0.8947 | High Similarity | NPC225434 |
0.8947 | High Similarity | NPC471457 |
0.8947 | High Similarity | NPC203050 |
0.8947 | High Similarity | NPC52382 |
0.8947 | High Similarity | NPC170675 |
0.8947 | High Similarity | NPC112755 |
0.8947 | High Similarity | NPC270578 |
0.8947 | High Similarity | NPC223747 |
0.8947 | High Similarity | NPC227508 |
0.8947 | High Similarity | NPC183036 |
0.8947 | High Similarity | NPC120099 |
0.8947 | High Similarity | NPC219904 |
0.8944 | High Similarity | NPC314020 |
0.8941 | High Similarity | NPC118284 |
0.8941 | High Similarity | NPC113968 |
0.8941 | High Similarity | NPC135599 |
0.8941 | High Similarity | NPC281131 |
0.8941 | High Similarity | NPC88789 |
0.8941 | High Similarity | NPC276222 |
0.8941 | High Similarity | NPC236934 |
0.8941 | High Similarity | NPC179950 |
0.8941 | High Similarity | NPC73855 |
0.8941 | High Similarity | NPC56077 |
0.8941 | High Similarity | NPC253662 |
0.8941 | High Similarity | NPC67037 |
0.8941 | High Similarity | NPC328940 |
0.8941 | High Similarity | NPC308404 |
0.8941 | High Similarity | NPC274618 |
0.8941 | High Similarity | NPC277174 |
0.8941 | High Similarity | NPC5778 |
0.8941 | High Similarity | NPC255615 |
0.8941 | High Similarity | NPC145038 |
0.8935 | High Similarity | NPC284960 |
0.8935 | High Similarity | NPC168822 |
0.8935 | High Similarity | NPC29830 |
0.8935 | High Similarity | NPC191306 |
0.8935 | High Similarity | NPC270335 |
0.8935 | High Similarity | NPC222936 |
0.8927 | High Similarity | NPC469650 |
0.892 | High Similarity | NPC473072 |
0.892 | High Similarity | NPC470446 |
0.892 | High Similarity | NPC36138 |
0.892 | High Similarity | NPC470445 |
0.892 | High Similarity | NPC107987 |
0.892 | High Similarity | NPC35924 |
0.892 | High Similarity | NPC297503 |
0.892 | High Similarity | NPC470449 |
0.892 | High Similarity | NPC97119 |
0.892 | High Similarity | NPC135831 |
0.892 | High Similarity | NPC470447 |
0.892 | High Similarity | NPC470718 |
0.892 | High Similarity | NPC199172 |
0.8914 | High Similarity | NPC198902 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC170203 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9112 | High Similarity | NPD3818 | Discontinued |
0.907 | High Similarity | NPD4338 | Clinical (unspecified phase) |
0.8844 | High Similarity | NPD6797 | Phase 2 |
0.8793 | High Similarity | NPD7251 | Discontinued |
0.8786 | High Similarity | NPD7074 | Phase 3 |
0.8786 | High Similarity | NPD7472 | Approved |
0.8743 | High Similarity | NPD7808 | Phase 3 |
0.8728 | High Similarity | NPD7054 | Approved |
0.869 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8639 | High Similarity | NPD4381 | Clinical (unspecified phase) |
0.8629 | High Similarity | NPD7993 | Clinical (unspecified phase) |
0.8555 | High Similarity | NPD6168 | Clinical (unspecified phase) |
0.8555 | High Similarity | NPD6167 | Clinical (unspecified phase) |
0.8555 | High Similarity | NPD6166 | Phase 2 |
0.8471 | Intermediate Similarity | NPD3882 | Suspended |
0.8462 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8457 | Intermediate Similarity | NPD7228 | Approved |
0.8402 | Intermediate Similarity | NPD1934 | Approved |
0.8372 | Intermediate Similarity | NPD6234 | Discontinued |
0.8305 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8304 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8294 | Intermediate Similarity | NPD37 | Approved |
0.8287 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.8286 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.8276 | Intermediate Similarity | NPD7199 | Phase 2 |
0.8268 | Intermediate Similarity | NPD6559 | Discontinued |
0.8256 | Intermediate Similarity | NPD4966 | Approved |
0.8256 | Intermediate Similarity | NPD4965 | Approved |
0.8256 | Intermediate Similarity | NPD4967 | Phase 2 |
0.8246 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8218 | Intermediate Similarity | NPD5494 | Approved |
0.8208 | Intermediate Similarity | NPD7075 | Discontinued |
0.8202 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8177 | Intermediate Similarity | NPD8312 | Approved |
0.8177 | Intermediate Similarity | NPD8313 | Approved |
0.8162 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.8146 | Intermediate Similarity | NPD3751 | Discontinued |
0.814 | Intermediate Similarity | NPD2801 | Approved |
0.8092 | Intermediate Similarity | NPD5402 | Approved |
0.809 | Intermediate Similarity | NPD7473 | Discontinued |
0.807 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8066 | Intermediate Similarity | NPD7240 | Approved |
0.8066 | Intermediate Similarity | NPD7685 | Pre-registration |
0.8047 | Intermediate Similarity | NPD1512 | Approved |
0.8035 | Intermediate Similarity | NPD7819 | Suspended |
0.8035 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8023 | Intermediate Similarity | NPD6232 | Discontinued |
0.8 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7977 | Intermediate Similarity | NPD6801 | Discontinued |
0.7957 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7953 | Intermediate Similarity | NPD1653 | Approved |
0.7929 | Intermediate Similarity | NPD1511 | Approved |
0.7921 | Intermediate Similarity | NPD3787 | Discontinued |
0.7898 | Intermediate Similarity | NPD3749 | Approved |
0.7895 | Intermediate Similarity | NPD5403 | Approved |
0.7857 | Intermediate Similarity | NPD3750 | Approved |
0.7849 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7824 | Intermediate Similarity | NPD6799 | Approved |
0.7817 | Intermediate Similarity | NPD8151 | Discontinued |
0.7778 | Intermediate Similarity | NPD5401 | Approved |
0.7765 | Intermediate Similarity | NPD6959 | Discontinued |
0.7759 | Intermediate Similarity | NPD6599 | Discontinued |
0.7744 | Intermediate Similarity | NPD7435 | Discontinued |
0.7738 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7714 | Intermediate Similarity | NPD7411 | Suspended |
0.7684 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.768 | Intermediate Similarity | NPD3926 | Phase 2 |
0.768 | Intermediate Similarity | NPD6782 | Approved |
0.768 | Intermediate Similarity | NPD6777 | Approved |
0.768 | Intermediate Similarity | NPD6781 | Approved |
0.768 | Intermediate Similarity | NPD6778 | Approved |
0.768 | Intermediate Similarity | NPD6776 | Approved |
0.768 | Intermediate Similarity | NPD6780 | Approved |
0.768 | Intermediate Similarity | NPD6779 | Approved |
0.7679 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7679 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7674 | Intermediate Similarity | NPD2533 | Approved |
0.7674 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7674 | Intermediate Similarity | NPD2534 | Approved |
0.7674 | Intermediate Similarity | NPD2532 | Approved |
0.7654 | Intermediate Similarity | NPD919 | Approved |
0.7633 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7629 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7602 | Intermediate Similarity | NPD6190 | Approved |
0.7585 | Intermediate Similarity | NPD5619 | Clinical (unspecified phase) |
0.7566 | Intermediate Similarity | NPD8150 | Discontinued |
0.756 | Intermediate Similarity | NPD3748 | Approved |
0.7541 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7528 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7512 | Intermediate Similarity | NPD7874 | Approved |
0.7512 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD230 | Phase 1 |
0.7475 | Intermediate Similarity | NPD7680 | Approved |
0.7475 | Intermediate Similarity | NPD7697 | Approved |
0.7475 | Intermediate Similarity | NPD7698 | Approved |
0.7475 | Intermediate Similarity | NPD7696 | Phase 3 |
0.7473 | Intermediate Similarity | NPD1247 | Approved |
0.7471 | Intermediate Similarity | NPD7266 | Discontinued |
0.7456 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7442 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7437 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7437 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7437 | Intermediate Similarity | NPD8319 | Approved |
0.7437 | Intermediate Similarity | NPD8320 | Phase 1 |
0.7425 | Intermediate Similarity | NPD1613 | Approved |
0.7425 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7423 | Intermediate Similarity | NPD6535 | Approved |
0.7423 | Intermediate Similarity | NPD6534 | Approved |
0.7413 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7412 | Intermediate Similarity | NPD2796 | Approved |
0.7389 | Intermediate Similarity | NPD7801 | Approved |
0.7389 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7389 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7341 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7321 | Intermediate Similarity | NPD943 | Approved |
0.731 | Intermediate Similarity | NPD7699 | Phase 2 |
0.731 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7303 | Intermediate Similarity | NPD3226 | Approved |
0.7303 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7283 | Intermediate Similarity | NPD6674 | Discontinued |
0.7283 | Intermediate Similarity | NPD2800 | Approved |
0.7278 | Intermediate Similarity | NPD1933 | Approved |
0.725 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7243 | Intermediate Similarity | NPD5711 | Approved |
0.7243 | Intermediate Similarity | NPD5710 | Approved |
0.7241 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7236 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7229 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7225 | Intermediate Similarity | NPD4665 | Approved |
0.7225 | Intermediate Similarity | NPD4111 | Phase 1 |
0.7219 | Intermediate Similarity | NPD1240 | Approved |
0.7209 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7207 | Intermediate Similarity | NPD7458 | Discontinued |
0.7192 | Intermediate Similarity | NPD7584 | Approved |
0.7191 | Intermediate Similarity | NPD920 | Approved |
0.7189 | Intermediate Similarity | NPD8127 | Discontinued |
0.7186 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD447 | Suspended |
0.7175 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7172 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD2346 | Discontinued |
0.7164 | Intermediate Similarity | NPD5006 | Approved |
0.7164 | Intermediate Similarity | NPD5005 | Approved |
0.7156 | Intermediate Similarity | NPD8155 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7143 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7135 | Intermediate Similarity | NPD1607 | Approved |
0.7115 | Intermediate Similarity | NPD7930 | Approved |
0.711 | Intermediate Similarity | NPD6099 | Approved |
0.711 | Intermediate Similarity | NPD6100 | Approved |
0.711 | Intermediate Similarity | NPD2935 | Discontinued |
0.7104 | Intermediate Similarity | NPD5353 | Approved |
0.7101 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD1243 | Approved |
0.7081 | Intermediate Similarity | NPD5537 | Clinical (unspecified phase) |
0.7076 | Intermediate Similarity | NPD6355 | Discontinued |
0.7075 | Intermediate Similarity | NPD7907 | Approved |
0.7073 | Intermediate Similarity | NPD7585 | Approved |
0.7068 | Intermediate Similarity | NPD5953 | Discontinued |
0.7062 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7052 | Intermediate Similarity | NPD2799 | Discontinued |
0.705 | Intermediate Similarity | NPD4420 | Approved |
0.7048 | Intermediate Similarity | NPD8404 | Phase 2 |
0.7041 | Intermediate Similarity | NPD4287 | Approved |
0.7039 | Intermediate Similarity | NPD6273 | Approved |
0.7024 | Intermediate Similarity | NPD7583 | Approved |
0.7021 | Intermediate Similarity | NPD5242 | Approved |
0.702 | Intermediate Similarity | NPD6214 | Clinical (unspecified phase) |
0.702 | Intermediate Similarity | NPD6213 | Phase 3 |
0.702 | Intermediate Similarity | NPD6212 | Phase 3 |
0.7018 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7011 | Intermediate Similarity | NPD4288 | Approved |
0.7 | Intermediate Similarity | NPD7799 | Discontinued |
0.7 | Intermediate Similarity | NPD3764 | Approved |
0.6995 | Remote Similarity | NPD8366 | Approved |
0.6995 | Remote Similarity | NPD4419 | Clinical (unspecified phase) |
0.699 | Remote Similarity | NPD6843 | Phase 3 |
0.699 | Remote Similarity | NPD6841 | Approved |
0.699 | Remote Similarity | NPD6842 | Approved |
0.6984 | Remote Similarity | NPD2403 | Approved |
0.6983 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6971 | Remote Similarity | NPD2344 | Approved |
0.6963 | Remote Similarity | NPD7286 | Phase 2 |
0.6961 | Remote Similarity | NPD4002 | Approved |
0.6961 | Remote Similarity | NPD4004 | Approved |
0.6954 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6954 | Remote Similarity | NPD7033 | Discontinued |
0.6946 | Remote Similarity | NPD3450 | Approved |
0.6946 | Remote Similarity | NPD2493 | Approved |
0.6946 | Remote Similarity | NPD3452 | Approved |
0.6946 | Remote Similarity | NPD2494 | Approved |
0.6928 | Remote Similarity | NPD9269 | Phase 2 |
0.6927 | Remote Similarity | NPD7390 | Discontinued |
PubChem CID   | 10416810 |
ChEMBL   | CHEMBL447361 |
ZINC   |
Molecular Weight:   | 650.08 |
ALogP:   | -5.4315 |
MLogP:   | 2.34 |
XLogP:   | -2.717 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 316.73 |
# H-Bond Aceptor:   | 13 |
# H-Bond Donor:   | 10 |
# Rings:   | 6 |
# Heavy Atoms:   | 46 |